Clinical trial

Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction

NCT00634829

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2008-02-01

PhasePHASE3

Study timeline

Study start (unknown)2008-02-01Date precision: month

Registry last updated2013-07-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Bronchospasmunresolved

Interventions

albuterol (Armstrong Albuterol HFA)DRUG

Albuterol Sulfate (Provenetil-HFA)DRUG

Placebo-HFADRUG

Sponsors & collaborators

Amphastar Pharmaceuticals, Inc.lead sponsor

Mapped research locations

DenverColorado, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00634829 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.